Biohaven Pharmaceutical Holding Company Ltd.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
7.69 |
7.81 |
117.39 |
331.50 |
763.40 |
1,220.36 |
| Przychód Δ r/r |
0.00% |
1.54% |
1402.95% |
182.40% |
130.28% |
59.86% |
| Przychód (min) |
2.06 |
2.60 |
29.78 |
328.79 |
204.15 |
326.35 |
| Przychód (max) |
14.82 |
19.72 |
211.30 |
334.22 |
1,470.69 |
2,351.03 |
| EBITDA (średnia) |
5.43 |
5.51 |
82.87 |
234.02 |
538.92 |
861.51 |
| EBIT (średnia) |
5.43 |
5.51 |
82.80 |
233.82 |
538.46 |
860.77 |
| EBIT % |
70.53% |
70.53% |
70.53% |
70.53% |
70.53% |
70.53% |
| Zysk netto (średni) |
-888.60 |
-703.62 |
-768.04 |
-693.06 |
-286.07 |
-138.52 |
| Zysk netto % |
-11551.73% |
-9008.57% |
-654.27% |
-209.06% |
-37.47% |
-11.35% |
| EPS (średnia) |
-8.89 |
-7.71 |
-6.36 |
-5.11 |
-3.14 |
-1.52 |
| Liczba analityków (Przychody) |
8 |
10 |
14 |
12 |
6 |
11 |
| Liczba analityków (EPS) |
10 |
6 |
9 |
11 |
5 |
4 |
| symbol |
BHVN |
BHVN |
BHVN |
BHVN |
BHVN |
BHVN |